1,451 results on '"Cornberg, Markus"'
Search Results
2. Impfungen bei Patienten mit chronischen Lebererkrankungen
3. Attenuated effector T cells are linked to control of chronic HBV infection
4. Experience and impact of stigma in people with chronic hepatitis B: a qualitative study in Asia, Europe, and the United States
5. Diagnostik und Therapie der Virushepatitis B und D im Jahr 2024
6. Clinical long-term outcome of hepatitis D compared to hepatitis B monoinfection
7. Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase III randomized trial
8. Folic acid supplementation is associated with a decreased mortality and reduced hospital readmission in patients with decompensated alcohol-related liver cirrhosis
9. Validation of Baveno VII criteria and other non-invasive diagnostic algorithms for clinically significant portal hypertension in hepatitis delta
10. Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure
11. CXCR6+CD69+ CD8+ T cells in ascites are associated with disease severity in patients with cirrhosis
12. Effects of renin–angiotensin inhibitors on renal function and the clinical course in patients with decompensated cirrhosis
13. HBV DNA and HBsAg Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and HBsAg Loss in HBeAg-Negative Patients Who Discontinued Antiviral Therapy
14. Therapie von COVID-19 unter Berücksichtigung von Lebererkrankungen
15. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
16. Hepatitis D virus infection: Pathophysiology, epidemiology and treatment. Report from the first international delta cure meeting 2022
17. Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-negative chronic hepatitis B: A multicentre cohort study
18. Differential Relapse Patterns After Discontinuation of Entecavir vs Tenofovir Disoproxil Fumarate in Chronic Hepatitis B
19. A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B
20. Treating hepatitis D with bulevirtide – Real-world experience from 114 patients
21. Sofosbuvir plus velpatasvir for 8 weeks in patients with acute hepatitis C: The HepNet acute HCV-V study
22. Altered and allele-specific open chromatin landscape reveals epigenetic and genetic regulators of innate immunity in COVID-19
23. Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial
24. Reverse inflammaging: Long-term effects of HCV cure on biological age
25. Early treatment of acute or recently acquired hepatitis C - an important tool on the path to HCV elimination!
26. THU-366 Use of proton pump inhibitors among German Hepatitis C patients treated with sofosbuvir/velpatasvir: Data from the German Hepatitis C-Registry (2016–2022)
27. TOP-400 Impact of bulevirtide given with or without nucleos (t)ide analogues on 48-week virologic outcomes in patients with chronic hepatitis delta virus infection
28. SAT-538-YI Differential phenotypes of γδ T cells in hepatitis E virus infection: implications for disease pathogenesis
29. SAT-363 Hepatocellular carcinoma development post hepatitis C virus cure is associated with distinct changes in the dynamics of the soluble inflammatory milieu
30. SAT-406-YI HBV dominance is associated with a distinct inflammatory milieu in HBV/HCV coinfection
31. FRI-107-YI Folic acid prescription is associated with a lower mortality and hospital readmission in patients with decompensated alcohol-related liver cirrhosis
32. SAT-533 Liver immunity index: predicting immune control of chronic hepatitis B from circulating CD8 T cells
33. FRI-109 Differences in the clinical phenotype of decompensated liver cirrhosis between MASLD, MetALD and ALD patients
34. WED-392 Improvement in liver histology is observed in most patients with chronic hepatitis delta after 48weeks of bulevirtide monotherapy
35. LBP-029 Efficacy and safety of 144 weeks of bulevirtide 2 mg or 10 mg monotherapy from the ongoing phase 3 study, MYR301
36. Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase 3 randomized trial
37. Safety and Effectiveness Using 8 Weeks of Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated Cirrhosis: The CREST Study
38. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
39. Fulminant parvovirus B19 myocarditis after chemotherapy: full recovery after antiviral therapy with tenofovir
40. Nosocomial infections in female compared with male patients with decompensated liver cirrhosis
41. Prediction of Sustained Response After Nucleo(s)tide Analogue Cessation Using HBsAg and HBcrAg Levels: A Multicenter Study (CREATE)
42. Off-Therapy Response After Nucleos(t)ide Analogue Withdrawal in Patients With Chronic Hepatitis B: An International, Multicenter, Multiethnic Cohort (RETRACT-B Study)
43. No value of non‐selective beta‐blockers after TIPS‐insertion.
44. Long‐term outcome of hepatitis delta in different regions world‐wide: Results of the Hepatitis Delta International Network.
45. Host response to influenza infections in human blood: association of influenza severity with host genetics and transcriptomic response.
46. Management of Patients with Acute Hepatitis C
47. Elevation of S2‐bound α1‐acid glycoprotein is associated with chronic hepatitis C virus infection and hepatocellular carcinoma
48. Factors influencing voriconazole plasma level in intensive care patients
49. Dynamic evolution of the sofosbuvir-associated variant A1343V in HEV-infected patients under concomitant sofosbuvir-ribavirin treatment
50. Diagnosis and treatment of viral hepatitis B and D in 2024
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.